文献速递脑血管病外科

脉络膜前动脉动脉瘤:手术与血管内治疗结局及缺血性并发症的系统评价与Meta分析

Anterior choroidal artery aneurysms: a systematic review and meta-analysis of outcomes and ischemic complications following surgical and endovascular treatment.
PubMed 文献 · J Neurosurg · 2024-08-09

该系统评价与Meta分析纳入25项研究共1627例脉络膜前动脉动脉瘤患者,比较手术夹闭、弹簧圈栓塞和血流导向治疗的并发症与结局;血流导向治疗的总并发症和缺血性并发症显著低于夹闭与栓塞,功能恢复更好。

要点

  • 全队列总并发症率11.6%,缺血性并发症率5.5%,良好恢复率90.3%。
  • 血流导向组总并发症1.3%、缺血性并发症0.7%、良好恢复98.4%,低于夹闭和栓塞。
  • 夹闭组总并发症17.6%、缺血性并发症9.4%,栓塞组分别为10.3%和3.0%。

核心结论

  • 血流导向治疗的总并发症和缺血性并发症显著低于夹闭与栓塞,结局更优。
  • 不同治疗类型之间结局可能存在差异,尤其需考虑指导治疗选择的不同患者表现。

研究设计与样本

  • 系统评价与单臂Meta分析,检索PubMed、Embase、Scopus和Cochrane数据库,纳入25项研究共1627例患者。
  • 患者中男性554例、女性1009例、性别未注明64例;夹闭1064例、栓塞443例、血流导向120例。

主要发现

  • 全队列总并发症率11.6%,缺血性并发症率5.5%,良好恢复率90.3%。
  • 夹闭组总手术并发症率17.6%,缺血性并发症率9.4%,良好功能恢复率88.0%,完全闭塞率84.5%。
  • 栓塞组并发症率10.3%,缺血性并发症率3.0%,良好功能恢复率88.6%,完全闭塞率74.1%。
  • 血流导向组并发症率1.3%,缺血性并发症率0.7%,良好功能恢复率98.4%,完全闭塞率79.0%。

关键数值与推荐

  • 良好功能恢复定义为Glasgow结局量表评分4-5分或改良Rankin量表评分0-2分。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Anterior choroidal artery (AChA) aneurysms account for 2%-5% of all intracranial aneurysms. Treatment considerations include microsurgical clipping, flow diversion, or coiling with or without adjunctive devices. AChA aneurysms pose challenges in treatment due to the origination of the aneurysm from the origin or proximal segment of the AChA. The AChA is particularly susceptible to vasospasm and occlusion during treatment with devastating neurological deficits, including hemiparesis, hemianesthesia, lethargy, neglect, and hemianopia. In this study, the authors performed a meta-analysis to quantify the outcomes and complication rates across treatment modalities for AChA aneurysms and to identify risk factors reported in the literature. METHODS: The authors performed a systematic review of AChA aneurysms treated with surgical clipping, endovascular coiling, or flow diversion and reported in the PubMed, Embase, Scopus, and Cochrane search databases. Single-arm meta-analyses of the selected outcomes were performed in RStudio. RESULTS: Literature review yielded 25 studies that met the inclusion criteria. In total, 1627 patients were included in the analysis, with 554 males, 1009 females, and 64 unspecified. The rate of any complication in the full cohort was 11.6%, with a rate of ischemic complications of 5.5% and a favorable recovery rate of 90.3% of all patients treated. In total, 1064 patients underwent surgical clipping, 443 were treated with coiling, and 120 patients with flow diversion. In clipped patients, the rate of total surgical complications was 17.6%, with an ischemic complication rate of 9.4%. The rate of good functional recovery, defined on the basis of a Glasgow Outcome Scale score of 4-5 or modified Rankin Scale score of 0-2, was 88.0%, and complete obliteration was achieved in 84.5% of surgically clipped aneurysms. The complication rate in coiled patients was 10.3%, with an ischemic complication rate of 3.0%. Good functional recovery was achieved in 88.6% of coiled patients and complete aneurysm obliteration in 74.1%. Flow diversion resulted in a complication rate of 1.3%, with 0.7% rate of ischemic complications. Good functional recovery was achieved in 98.4% of patients and complete aneurysm obliteration in 79.0% in the flow diversion group. Aneurysm morphological features that impacted the complication rate were also identified to augment quantitative data and to help guide treatment selection for AChA aneurysms. CONCLUSIONS: Flow diversion showed significantly lower total and ischemic complications and improved outcomes compared to clipping and coiling. There may be differences in outcomes between treatment types, especially when considering the varied patient presentations that guide treatment selection.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Barhouse P, Young M, Taussky P, et al. Anterior choroidal artery aneurysms: a systematic review and meta-analysis of outcomes and ischemic complications following surgical and endovascular treatment. J Neurosurg. 2024. PMID: 39126718. doi:10.3171/2024.4.JNS24362

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。